Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wheeler

Showing results (911-920 of 1,217) with videos related to

Pageof 122
Sort By:
Molecular Cancer Research : MCR|November 11, 2020
5-Azacytidine Transiently Restores Dysregulated Erythroid Differentiation Gene Expression in TET2-Deficient Erythroleukemia CellsBrian M Reilly, Timothy Luger, Soo Park, et al.
The New England Journal of Medicine|October 27, 2018
Intravenous Iron in Patients Undergoing Maintenance HemodialysisIain C Macdougall, Claire White, Stefan D Anker, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 5, 2024
SGLT2 Inhibitors - The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative ReviewSamuel Seidu, Vicki Alabraba, Sarah Davies, et al.
Journal of Huntington'S Disease|February 23, 2024
Somatic CAG Repeat Stability in a Transgenic Sheep Model of Huntington's DiseaseRenee R Handley, Suzanne J Reid, Zoe Burch, et al.
Kidney International Supplements|January 25, 2019
Complications of chronic kidney disease: current state, knowledge gaps, and strategy for actionAminu K Bello, Mona Alrukhaimi, Gloria E Ashuntantang, et al.
Kidney International|July 16, 2017
Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies ConferenceColin Baigent, William G Herrington, Josef Coresh, et al.
Kidney International|May 26, 2023
Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceElaine Ku, Lucia Del Vecchio, Kai-Uwe Eckardt, et al.
Kidney International|January 23, 2019
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceJürgen Floege, Sean J Barbour, Daniel C Cattran, et al.
The Lancet. Diabetes & Endocrinology|September 10, 2019
SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysisBrendon L Neuen, Tamara Young, Hiddo J L Heerspink, et al.
Human Molecular Genetics|September 22, 2017
A modifier of Huntington's disease onset at the MLH1 locusJong-Min Lee, Michael J Chao, Denise Harold, et al.
Pageof 122

Showing results (911-920 of 1,217) with videos related to

Sort By:
Pageof 122
Molecular Cancer Research : MCR|November 11, 2020
5-Azacytidine Transiently Restores Dysregulated Erythroid Differentiation Gene Expression in TET2-Deficient Erythroleukemia CellsBrian M Reilly, Timothy Luger, Soo Park, et al.
The New England Journal of Medicine|October 27, 2018
Intravenous Iron in Patients Undergoing Maintenance HemodialysisIain C Macdougall, Claire White, Stefan D Anker, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 5, 2024
SGLT2 Inhibitors - The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative ReviewSamuel Seidu, Vicki Alabraba, Sarah Davies, et al.
Journal of Huntington'S Disease|February 23, 2024
Somatic CAG Repeat Stability in a Transgenic Sheep Model of Huntington's DiseaseRenee R Handley, Suzanne J Reid, Zoe Burch, et al.
Kidney International Supplements|January 25, 2019
Complications of chronic kidney disease: current state, knowledge gaps, and strategy for actionAminu K Bello, Mona Alrukhaimi, Gloria E Ashuntantang, et al.
Kidney International|July 16, 2017
Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies ConferenceColin Baigent, William G Herrington, Josef Coresh, et al.
Kidney International|May 26, 2023
Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceElaine Ku, Lucia Del Vecchio, Kai-Uwe Eckardt, et al.
Kidney International|January 23, 2019
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceJürgen Floege, Sean J Barbour, Daniel C Cattran, et al.
The Lancet. Diabetes & Endocrinology|September 10, 2019
SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysisBrendon L Neuen, Tamara Young, Hiddo J L Heerspink, et al.
Human Molecular Genetics|September 22, 2017
A modifier of Huntington's disease onset at the MLH1 locusJong-Min Lee, Michael J Chao, Denise Harold, et al.
Pageof 122